Bcr-Abl induces abnormal cytoskeleton remodelling, β1 integrin clustering and increased cell adhesion to fibronectin through the Abl interactor 1 pathway

Journal of Cell Science

Volumn 120, Issue 8, 2007, Pages 1436-1446

  Li, Yingzhu ^a   Clough, Nancy ^a   Sun, Xiaolin ^a   Yu, Weidong ^a   Abbott, Brian L ^a   Hogan, Christopher J ^a,b   Dai, Zonghan ^a,b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

1 integrin; Abil; Actin cytoskeleton; Bcr Abl; Cell adhesion; WAVE2

Indexed keywords

ABELSON KINASE; ABELSON KINASE INTERACTOR 1; BCR ABL PROTEIN; BETA1 INTEGRIN; F ACTIN; FIBRONECTIN; PAXILLIN; PHOSPHATIDYLINOSITOL 3 KINASE; UNCLASSIFIED DRUG; VINCULIN;

ARTICLE; CELL ADHESION; CYTOSKELETON; ENZYME INHIBITION; GENE CLUSTER; GENE MUTATION; GENE TRANSLOCATION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA; MUSCLE FUNCTION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION;

ANTIGENS, CD29; CELL ADHESION; CELL LINE; CYTOSKELETON; FIBRONECTINS; FUSION PROTEINS, BCR-ABL; HUMANS;

EID: 34249110123     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.03430     Document Type: Article

References (49)

1. Bazzoni, G., Carlesso, N., Griffin, J. D. and Hemler, M. E. (1996). Bcr/Abl expression stimulates integrin function in hematopoietic cell lines. J. Clin. Invest. 98, 521-528.
2. Bhatia, R., McCarthy, J. B. and Verfaillie, C. M. (1996). Interferon-alpha restores normal beta 1 integrin-mediated inhibition of hematopoietic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia. Blood 87, 3883-3891.
3. Bhatia, R., Munthe, H. A. and Verfaillie, C. M. (1999). Role of abnormal integrin-cytoskeletal interactions in impaired betal integrin function in chronic myclogenous leukemia hematopoietic progenitors. Exp. Hematol. 27, 1384-1396.
4. Biesova, Z., Piccoli, C. and Wong, W. T. (1997). Isolation and characterization of e3B1, an eps8 binding protein that regulates cell growth. Oncogene 14, 233-241.
5. Bompard, G. and Caron, E. (2004). Regulation of WASP/WAVE proteins: making a long story short. J. Cell Biol. 166, 957-962.
6. Burns, S., Cory, G. O., Vainchenker, W. and Thrasher, A. J. (2004). Mechanisms of WASp-mediated hematologic and immunologic disease. Blood 104, 3454-3462.
7. Burridge, K., Fath, K., Kelly, T., Nuckolls, G. and Turner, C. (1988). Focal adhesions: transmembrane junctions between the extracellular matrix and the cytoskeleton. Annu. Rev. Cell Biol. 4, 487-525.
8. Courtney, K. D., Grove, M., Vandongen, H., Vandongen, A., LaMantia, A. S. and Pendergast, A. M. (2000). Localization and phosphorylation of Abl-interactor proteins, Abi-1 and Abi-2, in the developing nervous system. Mol. Cell. Neurosci. 16, 244-257.
9. Dai, Z. and Pendergast, A. M. (1995). Abi-2, a novel SH3-containing protein interacts with the c-AbI tyrosine kinase and modulates c-Abl transforming activity. Genes Dev. 9, 2569-2582.
10. Dai, Z., Quackenbush, R. C., Courtney, K. D., Grove, M., Cortez, D., Reuther, G. W. and Pendergast, A. M. (1998). Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway. Genes Dev. 12, 1415-1424.
11. Dai, Z., Kerzic, P., Schroeder, W. G. and McNiece, I. K. (2001). Deletion of the Src homology 3 domain and C-terminal proline-rich sequences in Bcr-Abl prevents Abl interactor 2 degradation and spontaneous cell migration and impairs leukemogenesis. J. Biol. Chem. 276, 28954-28960.
12. Eden, S., Rohatgi, R., Podtelejnikov, A. V., Mann, M. and Kirschner, M. W. (2002). Mechanism of regulation of WAVE1-induced actin nucleation by Rac1 and Nck. Nature 418, 790-793.
13. Gautreau, A., Ho, H. Y., Li, J., Steen, H., Gygi, S. P. and Kirschner, M. W. (2004). Purification and architecture of the ubiquitous Wave complex. Proc. Natl. Acad. Sci. USA 101, 4379-4383.
14. Gordon, M. Y., Dowding, C. R., Riley, G. P., Goldman, J. M. and Greaves, M. F. (1987). Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature 328, 342-344.
15. Hemmeryckx, B., van Wijk, A., Reichert, A., Kaartinen, V., de Jong, R., Pattengale, P. K., Gonzalez-Gomez, I., Groffen, J. and Heisterkamp, N. (2001). Crk1 enhances leukemogenesis in BCR/ABL P190 transgenic mice. Cancer Res. 61, 1398-1405.
16. Hynes, R. O. (2002). Integrins: bidirectional, allosteric signaling machines. Cell 110, 673-687.
17. Innocenti, M., Frittoli, E., Ponzanelli, I., Falck, J. R., Brachmann, S. M., Di Fiore, P. P. and Scita, G. (2003). Phosphoinositide 3-kinase activates Rac by entering in a complex with Eps8, Abil, and Sos-1. J. Cell Biol. 160, 17-23.
18. Innocenti, M., Zucconi, A., Disanza, A., Frittoli, E., Areces, L. B., Steffen, A., Stradal, T. E., Di Fiore, P. P., Carlier, M. F. and Scita, G. (2004). Abil is essential for the formation and activation of a WAVE2 signalling complex. Nat. Cell Biol. 6, 319-327.
19. Kramer, A., Horner, S., Willer, A., Fruehauf, S., Hochhaus, A., Hallek, M. and Hehlmann, R. (1999). Adhesion to fibronectin stimulates proliferation of wild-type and bcr/abl-transfected murine hematopoietic cells. Proc. Natl. Acad. Sci. USA 96 2087-2092.
20. Kunda, P., Craig, G., Dominguez, V. and Baum, B. (2003). Abi, Sra1, and Kette control the stability and localization of SCAR/WAVE to regulate the formation of actin-based protrusions. Curr Biol. 13, 1867-1875.
21. Leng, Y., Zhang, J., Badour, K., Arpaia, E., Freeman, S., Cheung, P., Siu, M. and Siminovitch, K. (2005). Abelson-interactor-1 promotes WAVE2 membrane translocation and Abelson-mediated tyrosine phosphorylation required for WAVE2 activation. Proc. Natl. Acad. Sci. USA 102, 1098-1103.
22. Martin, K. H., Slack, J. K., Boerner, S. A., Martin, C. C. and Parsons, J. T. (2002). Integrin connections map: to infinity and beyond. Science 296, 1652-1653.
23. McWhirter, J. R. and Wang, J. Y. (1997). Effect of Bcr sequences on the cellular function of the Bcr-Abl oncoprotein. Oncogene 15, 1625-1634.
24. Melo, J. V. and Deininger, M. W. (2004). Biology of chronic myelogenous leukemia-signaling pathways of initiation and transformation. Hematol. Oncol, Clin. North Am. 18, 545-569, vii-viii.
25. Miyazaki, K., Matsuda, S., Ichigotani, Y., Takenouchi, Y., Hayashi, K., Fukuda, Y., Nimura, Y. and Hamaguchi, M. (2000). Isolation and characterization of a novel human gene (NESH) which encodes a putative signaling molecule similar to e3B1 protein. Biochim. Biophys. Acta 1493, 237-241.
26. Musacchio, A., Noble, M., Pauptit, R., Wierenga, R. and Saraste, M. (1992). Crystal structure of a Src-homology 3 (SH3) domain. Nature 359, 851-855.
27. Pollard, T. D. and Borisy, G. G. (2003). Cellular motility driven by assembly and disassembly of actin filaments. Cell 112, 453-465.
28. Rao, J. and Li, N. (2004). Microfilament actin remodeling as a potential target for cancer drug development. Curr. Cancer Drug Targets 4, 345-354.
29. Ren, R., Ye, Z. S. and Baltimore, D. (1994). Ab1 protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites. Genes Dev. 8, 783-795.
30. Salesse, S. and Verfaillie, C. M. (2002). Mechanisms underlying abnormal trafficking and expansion of malignant progenitors in CML: BCR/ ABL-induced defects in integrin function in CML. Oncogene 21, 8605-8611.
31. Salgia, R., Li, J. L., Ewaniuk, D. S., Pear, W., Pisick, E., Burky, S. A., Ernst, T., Sattler, M., Chen, L. B. and Griffin, J. D. (1997). BCR/ABL induces multiple abnormalities of cytoskeletal function. J. Clin. Invest. 100, 46-57.
32. Salgia, R., Quackenbush, E., Lin, J., Souchkova, N., Sattler, M., Ewaniuk, D. S., Klucher, K. M., Daley, G. Q., Kraeft, S. K., Sackstein, R. et a]. (1999) The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1 alpha. Blood 94, 4233-4246.
33. Schwartz, M. A. and Ginsberg, M. H. (2002). Networks and crosstalk: integrin signalling spreads. Nat. Cell Biol. 4, E65-E68.
34. Schwartz, M. A., Schaller, M. D. and Ginsberg, M. H. (1995). Integrins: emerging paradigms of signal transduction. Annu. Rev. Cell Dev. Biol. 11, 549-599.
35. Shi, Y., Alin, K. and Goff, S. P. (1995). Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Ab1 protein, suppresses v-abl transforming activity. Genes Dev. 9, 2583-2597. i
36. Skorski, T., Nieborowska-Skorska, M., Wlodarski, P., Wasik, M., Trotta R., Kanakaraj, P., Salomoni, F., Antonyak, M., Martinez, R., Majewski, M. et al. (1998). The SH3 domain contributes to BCR/ ABL-dependent leukemogenesis in vivo: role in adhesion, invasion, and homing. Blood 91, 406-418.
37. Skourides, P. A., Perera, S. A. and Ren, R. (1999). Polarized distribution of Bcr-Abl in migrating myeloid cells and co-localization of Bcr-Abl and its target proteins. Oncogene 18, 1165-1176.
38. Steffen, A., Rottner, K., Ehinger, J., Innocenti, M., Scita, G., Wehland, J. and Stradal, T. E. (2004). Sra-1 and Nap1 link Rac to actin assembly driving lamellipodia formation. EMBO J. 23, 749-759.
39. Stradal, T. E., Rottner, K., Disanza, A., Confalonieri, S., Innocenti, M. and Scita, G. (2004). Regulation of actin dynamics by WASP and WAVE family proteins. Trends Cell Biol. 14, 303-311.
40. Teixido, J., Hemler, M. E., Greenberger, J. S. and Anklesaria, P. (1992). Role of beta 1 and beta 2 integrins in the adhesion of human CD34hi stem cells to bone marrow stroma. J. Clin. Invest. 90, 358-367.
41. Van Etten, R. A., Debnath, J., Zhou, H. and Cassanovas, J. M. (1995). Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-ab1 in vivo and abolishes binding of proline-rich ligands in vitro. Oncogene 10, 1977-1988.
42. Verfaillie, C. M., McCarthy, J. B. and McGlave, P. B. (1992). Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV. J. Clin. Invest. 90, 1232-1241.
43. Wang, B., Mysliwiec, T., Krainc, D., Jensen, R. A., Sonoda, G., Testa, J. R., Golemis, E. A. and Kruh, G. D. (1996). Identification of ArgBP1, an Arg protein tyrosine kinase binding protein that is the human homologue of a CNS-specific Xenopus gene. Oncogene 12, 1921-1929.
44. Wartmann, M., Hofer, P., Turowski, P., Saltiel, A. R. and Hynes, N. E. (1997). Negative modulation of membrane localization of the Raf-1 protein kinase by hyperphosphorylation. J. Biol. Chem. 272, 3915-3923.
45. Weiner, O. D., Rentel, M. C., Ott, A., Brown, G. E., Jedrychowski, M., Yaffe, M. B., Gygi, S. P., Cantley, L. C., Bourne, H. R. and Kirschner, M. W. (2006).,Hem-1 complexes are essential for Rac activation, actin polymerization, and myosin regulation during neutrophil chemotaxis. PLoS Biol. 4, e38.
46. Wertheim, J. A., Forsythe, K, Druker, B. J., Hammer, D., Boettiger, D. and Pear, W. S. (2002). BCR-ABL-induced adhesion defects are tyrosine kinase-independent. Blood 99, 4122-4130.
47. Wertheim, J. A., Perera, S. A., Hammer, D. A., Ren, R., Boettiger, D. and Pear, W. S. (2003). Localization of BCR-ABL to F-actin regulates cell adhesion but does not attenuate CML development. Blood 102, 2220-2228.
48. Williams, D. A., Rios, M., Stephens, C. and Patel, V. P. (1991). Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions. Nature 352, 438-441.
49. Ziemnicka-Kotula, D., Xu, J., Gu, H., Potempska, A., Kim, K. S., Jenkins, E. C., Trenkner, E. and Kotula, L. (1998). Identification of a candidate human spectrin Src homology 3 domain-binding protein suggests a general mechanism of association of tyrosine kinases with the spectrin-based membrane skeleton. J. Biol. Chem. 273, 13681-13692.